Bank Of Baroda Stock Price Outlook After Q1 FY27 Earnings: NII Up, One-Off Charge Hits Profit
.webp)
Key Takeaways
- Bank of Baroda posted Q1 FY27 results with net profit down 72% YoY to Rs 1,278 crore, due to a one-off US$600 million NMC Health settlement.
- Net interest income rose 9% YoY to Rs 12,524 crore, and global advances grew 17% YoY to Rs 14.16 lakh crore.
- Brokerages trimmed targets: JM Financial to Rs 270; Motilal Oswal to Rs 275; Systematix to Rs 290; Dolat Capital to Rs 250.
- The stock traded around Rs 246.45 prior to the earnings day, with global NIM at 2.77% and gross NPA at 1.99%.
Bank Of Baroda stock price moved in a mixed fashion after the Q1 FY27 earnings release, where a heavy one-off charge overshadowed otherwise resilient core growth. The quarterly numbers show a healthy rise in net interest income and robust loan growth, but the one-off item weighs on reported profitability. The question every retail investor asks now is: Does this news change the investment case for the Bank Of Baroda stock price?
Q1 FY27 net profit declined 72% YoY to Rs 1,278 crore, largely due to a one-off exceptional item of US$600 million tied to the NMC Health settlement. Net interest income (NII) rose 9% YoY to Rs 12,524 crore, while operating income fell slightly to Rs 15,995 crore and operating profit declined 1% YoY to Rs 8,127 crore. Total provisions and contingencies rose to Rs 6,323 crore, mainly due to the exceptional item. Global advances grew 17% YoY to Rs 14.16 lakh crore and global deposits rose 14% YoY to Rs 16.33 lakh crore. Global net interest margin stood at 2.77% for Q1 FY27, vs 2.91% a year earlier and 2.89% in Q4 FY26. Domestic NIM stood at 2.93%.
Cost of deposits declined to 4.66%, down 12 basis points sequentially and 39 basis points year-on-year. The gross NPA ratio stood at 1.99% in Q1 FY27, vs 2.28% in Q1 FY26 and 1.89% in Q4 FY26. Net NPA ratio declined to 0.50% from 0.60% a year earlier, but was higher than 0.45% in the March quarter. For investors focusing on the core bank health, the bank of baroda nim shows margin management remains a key challenge, with the overall margins operating in the 2.75%–2.95% range for the quarter.
Bank of Baroda earnings were significantly affected by the one-off NMC Health settlement, but excluding that charge, the earnings would show stronger growth – PAT would have grown about 22% YoY and RoA would have been around 1.1%. These nuances are essential for modeling the stock price trajectory and evaluating risk-reward in Bank Of Baroda stock price.
Brokerage responses were swift. JM Financial cut its target price to Rs 270 from Rs 290, noting the NMC charge and higher credit costs. Motilal Oswal Financial Services trimmed to Rs 275 with a Neutral stance, assuming NIMs in the roughly 2.75%–2.95% band and a 12%–14% credit growth trajectory for FY28. Systematix Institutional Equities lowered its target to Rs 290 from Rs 300, noting that excluding the one-off item, the core performance remained healthy. Dolat Capital gave a more cautious view with a target of Rs 250 and a Reduce rating. These revisions collectively imply a muted near-term upside but a clear path to outperformance if margins stabilize and credit costs moderate.
Investors should note that the previous close around Rs 246.45 suggests modest upside to the revised targets, depending on margin and credit-cost trajectories in the coming quarters. For deeper, data-driven stock analysis, try Swastika's Sarthi AI stock assistant: Swastika's Sarthi AI stock assistant.
Below is a concise snapshot of the quarter’s key metrics to help readers compare YoY performance and to anchor future discussions on Bank Of Baroda stock price.
| Metric | Q1 FY27 Value | YoY / Notes |
|---|---|---|
| Net Profit | Rs 1,278 crore | Declined 72% YoY due to one-off NMC item |
| NII | Rs 12,524 crore | Up 9% YoY |
| Operating Income | Rs 15,995 crore | Slight decline |
| Operating Profit | Rs 8,127 crore | Down 1% YoY |
| Total Provisions | Rs 6,323 crore | Elevated due to one-off item |
| Global Advances | Rs 14.16 lakh crore | Up 17% YoY |
| Global Deposits | Rs 16.33 lakh crore | Up 14% YoY |
| Global NIM | 2.77% | Vs 2.91% YoY; 2.89% Q4 FY26 |
| Domestic NIM | 2.93% | To be announced |
| Cost of Deposits | 4.66% | Down 12 bps QoQ; down 39 bps YoY |
| Gross NPA | 1.99% | Vs 2.28% YoY; 1.89% Q4 FY26 |
| Net NPA | 0.50% | Down from 0.60% YoY; above 0.45% March quarter |
| One-off Item | US$600 million | NMC Health settlement |
What The Q1 FY27 Numbers Say About Growth And Asset Quality
Despite the significant profit impact from the one-off item, the Bank Of Baroda earnings narrative preserves several positive threads. The 9% YoY rise in NII to Rs 12,524 crore signals continued strength in interest income, supported by healthy loan growth in the global book. The 17% YoY expansion in global advances to Rs 14.16 lakh crore coupled with 14% YoY growth in deposits to Rs 16.33 lakh crore shows the bank’s funding and disbursement momentum remains intact. Margin dynamics, however, remain a point of concern, with Global NIM at 2.77% and Domestic NIM at 2.93%, highlighting pressure on spreads even as asset growth remains robust. The sequential margin trend observed in Q4 FY26 continues to be watched by investors and analysts who model the stock price under a margin-light scenario.
From an asset-quality perspective, the gross NPA ratio at 1.99% is better than the previous year’s 2.28% and improved from 1.89% in Q4 FY26, while the net NPA ratio declined to 0.50% from 0.60% YoY but remained above the 0.45% level seen in the March quarter. The bank’s cost of deposits at 4.66% marks a decline of 12 basis points sequentially and 39 basis points year-on-year, underscoring operational efficiency gains even as margins compress. For investors tracking the nim dynamics, bank of baroda nim currently sits within the 2.75%–2.95% corridor, with domestic and global components contributing to this mix. These metrics collectively suggest a bank in growth mode, albeit with a margin normalization risk that could impact near-term profitability.
To contextualize, the one-off item underscores the importance of separating reported earnings from operating performance when projecting future Bank Of Baroda stock price trajectories. In this frame, the 17% loan growth and 14% deposit growth illustrate a strong franchise, while the margin compression remains the primary swing factor for near-term returns.
One-Off NMC Health Settlement: A Hidden Driver Of Profitability And What It Means For Bank Of Baroda Stock Price
The one-off exceptional item tied to the NMC Health settlement is the primary driver of a profit drop in Q1 FY27. Excluding this charge, the reported PAT would have grown about 22% YoY, and return on assets (RoA) would have been around 1.1%. This is a crucial nuance for modeling the Bank Of Baroda stock price, because it highlights the difference between reported numbers and underlying operating performance. In a bank’s earnings cadence, such one-off costs can distort the true trajectory of earnings growth, and many investors will want to separate structural profitability from exceptional items when assessing value and future price momentum. The market will likely weigh whether the NMC settlement is an outlier or a potential recurring risk factor in future quarters.
Broker Reactions And Price Targets After The Earnings
Brokerages quickly updated their stance on Bank Of Baroda stock price as soon as the earnings hit. JM Financial cut its target price to Rs 270 from Rs 290, noting the NMC charge and higher credit costs. JM Financial also maintained its Add rating on Bank Of Baroda shares, emphasizing that core metrics remain supportive if margins stabilize. Motilal Oswal Financial Services trimmed to Rs 275 with a Neutral stance, assuming NIMs in the roughly 2.75%–2.95% band and a 12%–14% credit growth trajectory for FY28. Systematix Institutional Equities lowered its target to Rs 290 from Rs 300, noting that excluding the one-off item, the core performance remained healthy. Dolat Capital gave a more cautious view with a target of Rs 250 and a Reduce rating. These revisions collectively imply a muted near-term upside but a clear path to outperformance if margins stabilize and credit costs moderate.
How To Position Bank Of Baroda Stock Price For Retail Investors: Risks And Opportunities
From an investor’s standpoint, the Q1 FY27 print reinforces the idea that Bank Of Baroda stock price is a play on margin stability alongside growth in core assets. The 17% growth in global advances and 14% growth in deposits are positive indicators of operating leverage as the bank scales lending while maintaining liquidity. Yet, the ongoing margin pressure, reflected in the 2.77% global NIM and 2.93% domestic NIM, means investors should temper near-term performance expectations with the reality of a potential margin normalization. The 0.50% net NPA is a positive sign given the 0.60% YoY level, but further improvement would be needed to raise ROA from the roughly 1% range that the bank has shown in recent quarters. A disciplined approach would track both the NII trajectory and the cost of deposits as levers for margin expansion or compression, and to watch how the NMC-driven one-off item resolves in subsequent quarters.
Related Reads
Frequently Asked Questions
What were Bank of Baroda's Q1 FY27 results?
Net profit: Rs 1,278 crore; NII: Rs 12,524 crore; Operating income: Rs 15,995 crore; Operating profit: Rs 8,127 crore; Provisions: Rs 6,323 crore; Global advances: Rs 14.16 lakh crore; Global deposits: Rs 16.33 lakh crore; Global NIM: 2.77%; Domestic NIM: 2.93%; Gross NPA: 1.99%; Net NPA: 0.50%; One-off item: US$600 million NMC Health settlement.
Why did Bank of Baroda's profit drop in Q1 FY27?
Profit fell 72% YoY primarily due to a one-off exceptional item of US$600 million related to the NMC Health settlement; excluding the one-off, PAT would have grown about 22% YoY.
How did the NIM and NPA metrics look in Q1 FY27?
Global NIM was 2.77% (vs 2.91% YoY and 2.89% in Q4 FY26); Domestic NIM was 2.93%; Gross NPA 1.99%; Net NPA 0.50%.
What were brokerages' reactions to Bank of Baroda's Q1 FY27 earnings?
Brokerages trimmed targets: JM Financial to Rs 270 (from Rs 290) and maintained Add rating; Motilal Oswal to Rs 275 (Neutral); Systematix to Rs 290 (Buy); Dolat Capital to Rs 250 (Reduce).
What does this mean for retail investors considering Bank Of Baroda stock price?
The one-off charge clouds near-term profitability, but core metrics show resilience: NII growth, asset growth, and a margin band around 2.75%–2.95%. Investors should watch margin stabilization, credit costs, and management guidance in coming quarters, and consider staged exposure.
Conclusion
Bank Of Baroda stock price is navigating a nuanced quarter where solid NII growth and funding momentum meet the drag of a one-off settlement. For the retail investor, the key takeaway is to recognize that a large portion of the profit decline is non-recurring, while the underlying balance-sheet metrics look resilient enough to support a positive path if margins stabilize and credit costs stay in check. The prudent step is to monitor margin normalization, credit-cost trajectories, and management guidance in the next two to three quarters, using them to calibrate risk and reward before adding or increasing exposure.
In practice, a staged approach–start with a small allocation, watch for improved NIM stability in the 2.75%–2.95% range, and reassess after the next quarterly print–could help retail investors capitalize on any catch-up in Bank Of Baroda stock price while mitigating downside risk from continued one-off exposure.
Open your trading and demat account here
Reference :
1 : Economictimes
.avif)
.avif)
.avif)
